1vr1

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1vr1.gif|left|200px]]
+
{{Seed}}
 +
[[Image:1vr1.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1vr1| PDB=1vr1 | SCENE= }}
{{STRUCTURE_1vr1| PDB=1vr1 | SCENE= }}
-
'''Specifity for Plasminogen Activator Inhibitor-1'''
+
===Specifity for Plasminogen Activator Inhibitor-1===
-
==Overview==
+
<!--
-
Substitution of the native variable region-1 (VR1/37-loop) of thrombin by the corresponding VR1 of tissue-type plasminogen activator (thrombin-VR1(tPA)) increases the rate of inhibition by plasminogen activator inhibitor type 1 (PAI-1) by three orders of magnitude, and is thus sufficient to confer PAI-1 specificity to a heterologous serine protease. A structural and kinetical approach to establish the function of the VR1 loop of t-PA in the context of the thrombin-VR1(tPA) variant is described. The crystal structure of thrombin-VR1(tPA) was resolved and showed a conserved overall alpha-thrombin structure, but a partially disordered VR1 loop as also reported for t-PA. The contribution of a prominent charge substitution close to the active site was studied using charge neutralization variants thrombin-E39Q(c39) and thrombin-VR1(tPA)-R304Q(c39), resulting in only fourfold changes in the PAI-1 inhibition rate. Surface plasmon resonance revealed that the affinity of initial reversible complex formation between PAI-1 and catalytically inactive Ser195--&gt;Ala variants of thrombin and thrombin-VR1(tPA) is only increased fivefold, i.e. KD is 652 and 128 nM for thrombin-S195A and thrombin-S195A-VR1(tPA), respectively. We established that the partition ratio of the suicide substrate reaction between the proteases and PAI-1 was largely unaffected in any variant studied. Hirugen allosterically decreases the rate of thrombin inhibition by PAI-1 2.5-fold and of thrombin-VR1(tPA) 20-fold, by interfering with a unimolecular step in the reaction, not by decreasing initial complex formation or by altering the stoichiometry. Finally, kinetic modeling demonstrated that acylation is the rate-limiting step in thrombin inhibition by PAI-1 (k approximately 10(-3) s(-1)) and this kinetic block is alleviated by the introduction of the tPA-VR1 into thrombin (k&gt;1 s(-1)). We propose that the length, flexibility and different charge architecture of the VR1 loop of t-PA invoke an induced fit of the reactive center loop of PAI-1, thereby enhancing the rate of acylation in the Michaelis complex between thrombin-VR1(t-PA) and PAI-1 by more than two orders of magnitude.
+
The line below this paragraph, {{ABSTRACT_PUBMED_10543954}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 10543954 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_10543954}}
==About this Structure==
==About this Structure==
Line 29: Line 33:
[[Category: Stoop, A A.]]
[[Category: Stoop, A A.]]
[[Category: Thrombin]]
[[Category: Thrombin]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 12:49:02 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 29 07:38:01 2008''

Revision as of 04:38, 29 July 2008

Template:STRUCTURE 1vr1

Specifity for Plasminogen Activator Inhibitor-1

Template:ABSTRACT PUBMED 10543954

About this Structure

1VR1 is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop., Dekker RJ, Eichinger A, Stoop AA, Bode W, Pannekoek H, Horrevoets AJ, J Mol Biol. 1999 Oct 29;293(3):613-27. PMID:10543954

Page seeded by OCA on Tue Jul 29 07:38:01 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools